177 related articles for article (PubMed ID: 33818292)
1. The role of Rezūm ™ team ablation of the prostate in the treatment of patients with acute urinary retention secondary to benign prostatic hyperplasia. A single center, single surgeon case series and literature review.
Wong A; Mahmalji W
Aging Male; 2020 Dec; 23(5):1620-1626. PubMed ID: 33818292
[TBL] [Abstract][Full Text] [Related]
2. The effect of acute urinary retention on the results of transurethral resection of the prostate.
Baran C
Urologia; 2023 Nov; 90(4):642-646. PubMed ID: 37491943
[TBL] [Abstract][Full Text] [Related]
3. Rezūm for retention-retrospective review of water vaporization therapy in the management of urinary retention in men with benign prostatic hyperplasia.
Bassily D; Wong V; Phillips JL; Fraiman M; Bauer R; Dixon CM; Wong NC
Prostate; 2021 Oct; 81(14):1049-1054. PubMed ID: 34287992
[TBL] [Abstract][Full Text] [Related]
4. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
Khan M; Khan AL; Khan S; Nawaz H
J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
[TBL] [Abstract][Full Text] [Related]
5. Rezŭm water vaporization therapy versus transurethral resection of the prostate in the management of refractory urine retention: matched pair comparative multicenter experience.
Tayeb W; Azhar RA; Subahi M; Munshi S; Qarni A; Bakhsh A; Sejiny M; Almohaisen T; Alammari A; Elkoushy MA
World J Urol; 2024 Jan; 42(1):48. PubMed ID: 38244100
[TBL] [Abstract][Full Text] [Related]
6. [Transurethral plasma resection of the prostate for acute urinary retention in patients with advanced prostate cancer].
Pang K; Liang Q; Chen B; Shi ZD; Dong Y; Han CH
Zhonghua Nan Ke Xue; 2023 Jan; 29(1):25-30. PubMed ID: 37846828
[TBL] [Abstract][Full Text] [Related]
7. What Is New with Rezūm Water Vapor Thermal Therapy for LUTS/BPH?
Doppalapudi SK; Gupta N
Curr Urol Rep; 2021 Jan; 22(1):4. PubMed ID: 33403529
[TBL] [Abstract][Full Text] [Related]
8. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
[TBL] [Abstract][Full Text] [Related]
9. Rezūm water vapor therapy for the treatment of patients with urinary retention and permanent catheter dependence secondary to benign prostate hyperplasia: a systematic review of the literature.
Spinos T; Katafigiotis I; Leotsakos I; Grivas N; Zabaftis C; Ermidis D; Sfoungaristos S; Karavitakis M
World J Urol; 2023 Feb; 41(2):413-420. PubMed ID: 36534152
[TBL] [Abstract][Full Text] [Related]
10. Urodynamic impact of acute urinary retention in patients with benign prostatic hyperplasia: a 2-year follow-up after transurethral resection of the prostate.
Wagenlehner FM; Bescherer K; Wagenlehner C; Zellner M; Weidner W; Naber KG
Urol Int; 2011; 86(1):73-9. PubMed ID: 20689259
[TBL] [Abstract][Full Text] [Related]
11. Rezūm water vapor therapy for catheter-dependent urinary retention: a real-world Canadian experience.
Elterman DS; Bhojani N; Vannabouathong C; Chughtai B; Zorn KC
Can J Urol; 2022 Apr; 29(2):11075-11079. PubMed ID: 35429425
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
[TBL] [Abstract][Full Text] [Related]
13. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
Desgrandchamps F; De La Taille A; Doublet JD;
BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
[TBL] [Abstract][Full Text] [Related]
14. Introduction of Rezum system technology to Ireland for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a pilot study on early outcomes and procedure cost analysis.
Haroon UM; Khan JS; McNicholas D; Forde JC; Davis NF; Power RE
Ir J Med Sci; 2022 Feb; 191(1):421-426. PubMed ID: 33599918
[TBL] [Abstract][Full Text] [Related]
15. Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy.
Yu SC; Cho CC; Hung EH; Chiu PK; Yee CH; Ng CF
Cardiovasc Intervent Radiol; 2017 Jan; 40(1):33-40. PubMed ID: 27853823
[TBL] [Abstract][Full Text] [Related]
16. Management of acute urinary retention secondary to benign prostatic hyperplasia in the UK: a national survey.
Manikandan R; Srirangam SJ; O'Reilly PH; Collins GN
BJU Int; 2004 Jan; 93(1):84-8. PubMed ID: 14678374
[TBL] [Abstract][Full Text] [Related]
17. Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study.
Chen JS; Chang CH; Yang WH; Kao YH
BJU Int; 2012 Dec; 110(11 Pt C):E896-901. PubMed ID: 23035623
[TBL] [Abstract][Full Text] [Related]
18. The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention.
He LY; Zhang YC; He JL; Li LX; Wang Y; Tang J; Tan J; Zhong K; Tang YX; Long Z
Asian J Androl; 2016; 18(1):134-9. PubMed ID: 26178398
[TBL] [Abstract][Full Text] [Related]
19. Predicting the risk of failed trial without catheter following Rezum™ therapy.
Coscarella M; Al Barajraji M; Moussa I; Hombert L; Naudin M; Roumeguère T
World J Urol; 2024 Mar; 42(1):129. PubMed ID: 38460028
[TBL] [Abstract][Full Text] [Related]
20. Saline bladder infusion vs standard catheter removal in patients with acute urinary retention related to benign prostatic hyperplasia: The BLAPERF Study.
Corral R; Boissier R; Depaquit TL; Gondran-Tellier B; Bastide C; Lechevallier E; Baboudjian M
Prog Urol; 2023 May; 33(6):319-324. PubMed ID: 36842924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
